Salveen Richter Analyst PerformanceAnalyst at Roth CapitalSalveen Richter is a stock analyst at Roth Capital focused in the healthcare sector, covering 32 publicly traded companies. Over the past year, Salveen Richter has issued 41 stock ratings, including buy, hold, and sell recommendations. While full access to Salveen Richter's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Salveen Richter's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings74 Last 11 YearsBuy Recommendations47.30% 35 Buy RatingsCompanies Covered32 Unique Companies Ratings Distribution74RatingsDistribution of strong buy, buy, hold, and sell ratings by Salveen Richter.RatingPercentageCount Strong Buy1.4%1 ratings Buy45.9%34 ratings Hold44.6%33 ratings Sell8.1%6 ratingsOut of 74 total stock ratings issued by Salveen Richter at Roth Capital, the majority (45.9%) have been Buy recommendations, followed by 44.6% Hold, 8.1% Sell, and 1.4% Strong Buy.Best & Worst CallsBest Call0000.0%FDMTMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%SGENFeb 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ96.9% of companies on NASDAQ31 companiesNYSE3.1% of companies on NYSE1 companySalveen Richter, an analyst at Roth Capital, currently covers 32 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare30 companies93.8%Miscellaneous1 company3.1%Industrials1 company3.1%Salveen Richter of Roth Capital specializes in stock coverage within the Healthcare sector, with additional focus on and Industrials companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY29 companies90.6%Miscellaneous1 company3.1%GROUND TRANSPORTATION1 company3.1%LIFE SCIENCES TOOLS & SERVICES1 company3.1% Salveen Richter's Ratings History at Roth Capital Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsRAREUltragenyx Pharmaceutical9/4/2026Lower Price Target$15.68$19.00Neutral$0.0000.00% ROIBRVEBraveheart Bio8/31/2026Initiated Coverage$27.44$48.00Buy$0.0000.00% ROIBRVEBraveheart Bio8/31/2026Initiated Coverage$25.50$48.00Buy$0.0000.00% ROIMRNAModerna8/19/2026Boost Price Target$175.17$120.00Neutral$0.0000.00% ROIELVNEnliven Therapeutics8/6/2026Boost Price Target$59.70$80.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals7/29/2026Reiterated Rating$54.04$69.00Neutral$0.0000.00% ROICARAvis Budget Group7/24/2026Boost Price Target$159.04$95.00Sell$0.0000.00% ROIRLAYRelay Therapeutics7/21/2026Boost Price Target$19.18$31.00Buy$0.0000.00% ROITSHATaysha Gene Therapies7/21/2026Boost Price Target$5.58$13.00Buy$0.0000.00% ROIMRNAModerna7/21/2026Boost Price Target$59.49$67.00Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ELVNEnliven Therapeutics7/21/2026Boost Price Target$51.67$67.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals6/24/2026Boost Price Target$76.52$75.00Neutral$0.0000.00% ROIQUREuniQure6/18/2026Boost Price Target$48.16$46.00Neutral$0.0000.00% ROIANNXAnnexon5/12/2026Initiated Coverage$5.68$7.00Neutral$0.0000.00% ROIANNXAnnexon5/12/2026Initiated Coverage$5.44$7.00Neutral$0.0000.00% ROIBMRNBioMarin Pharmaceutical5/11/2026Initiated Coverage$54.06$69.00Neutral$0.0000.00% ROIELVNEnliven Therapeutics5/8/2026Boost Price Target$40.48$59.00Buy$0.0000.00% ROIMRNAModerna5/1/2026Boost Price Target$45.37$49.00Neutral$0.0000.00% ROIRLAYRelay Therapeutics4/28/2026Boost Price Target$14.95$22.00Buy$0.0000.00% ROINTLAIntellia Therapeutics4/28/2026Boost Price Target$13.01$9.00Sell$0.0000.00% ROIQUREuniQure4/20/2026Boost Price Target$17.58$10.00Neutral$0.0000.00% ROIAGIOAgios Pharmaceuticals4/1/2026Boost Price Target$34.38$32.00Neutral$0.0000.00% ROIDNLIDenali Therapeutics3/26/2026Boost Price Target$20.65$40.00Buy$0.0000.00% ROIRAREUltragenyx Pharmaceutical3/24/2026Downgrade$20.27$25.00Neutral$0.0000.00% ROIGENBGenerate Biomedicines3/24/2026Initiated Coverage$12.52$26.00Buy$0.0000.00% ROIQUREuniQure3/3/2026Lower Price Target$9.07$9.00Neutral$0.0000.00% ROIMRNAModerna2/17/2026Boost Price Target$42.48$41.00Neutral$0.0000.00% ROIBIIBBiogen2/9/2026Reiterated Rating$195.33Buy$0.0000.00% ROIRCUSArcus Biosciences1/12/2026Upgrade$21.25$28.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals1/12/2026Reiterated Rating$23.20$19.00Sell$0.0000.00% ROIBIIBBiogen1/8/2026Reiterated Rating$186.91$225.00Buy$0.0000.00% ROIAGIOAgios Pharmaceuticals11/20/2025Lower Price Target$22.34$25.00Neutral$0.0000.00% ROIFOLDAmicus Therapeutics11/5/2025Boost Price Target$9.26$11.00Neutral$0.0000.00% ROIQUREuniQure11/4/2025Lower Price Target$34.29$38.00Neutral$0.0000.00% ROIRCUSArcus Biosciences10/30/2025Boost Price Target$20.21$16.00Neutral$0.0000.00% ROIIONSIonis Pharmaceuticals9/26/2025Upgrade$62.97$65.00Neutral$0.0000.00% ROIAPLSApellis Pharmaceuticals9/26/2025Downgrade$22.22$18.00Sell$0.0000.00% ROIQUREuniQure9/25/2025Boost Price Target$49.99$56.00Neutral$0.0000.00% ROIIMNMImmunome9/22/2025Initiated Coverage$9.39$26.00Buy$0.0000.00% ROIIMNMImmunome9/22/2025Initiated Coverage$9.77$26.00Buy$0.0000.00% ROIReady to give options a try? Your first trade (Ticker included) -INSIDE (Ad)Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.Send me my free guideALNYAlnylam Pharmaceuticals9/16/2025Boost Price Target$461.42$566.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals9/3/2025Boost Price Target$61.17$45.00Sell$00.0000.00% ROIFDMT4D Molecular Therapeutics8/12/2025Lower Price Target$6.17$38.00Buy$00.0000.00% ROISRPTSarepta Therapeutics8/7/2025Boost Price Target$17.42$19.00Neutral$00.0000.00% ROIACADACADIA Pharmaceuticals8/7/2025Boost Price Target$23.89$17.00Sell$00.0000.00% ROISRPTSarepta Therapeutics6/17/2025Downgrade$22.03$29.00Hold$00.0000.00% ROIELVNEnliven Therapeutics6/16/2025Initiated Coverage$21.91$37.00Buy$00.0000.00% ROIFDMT4D Molecular Therapeutics5/9/2025Lower Price Target$3.06$44.00Buy$00.0000.00% ROIRCUSArcus Biosciences5/8/2025Lower Price Target$8.14$13.00Neutral$00.0000.00% ROICRSPCRISPR Therapeutics5/8/2025Lower Price Target$35.40$47.00Neutral$00.0000.00% ROISRPTSarepta Therapeutics5/7/2025Lower Price Target$37.52$100.00Buy$00.0000.00% ROIBMRNBioMarin Pharmaceutical5/5/2025Lower Price Target$62.48$104.00Buy$00.0000.00% ROIFOLDAmicus Therapeutics5/2/2025Lower Price Target$6.56$9.00Neutral$0.0000.00% ROIREGNRegeneron Pharmaceuticals4/30/2025Lower Price Target$590.09$804.00Buy$000.0000.00% ROIBIIBBiogen4/23/2025Lower Price Target$120.33$197.00Buy$000.0000.00% ROIREGNRegeneron Pharmaceuticals4/14/2025Lower Price Target$560.49$917.00Buy$000.0000.00% ROIADPTAdaptive Biotechnologies3/21/2025Upgrade$7.75$9.00Buy$00.0000.00% ROISMMTSummit Therapeutics2/28/2025Initiated Coverage$18.49$42.00Buy$00.0000.00% ROICRSPCRISPR Therapeutics2/13/2025Lower Price Target$42.93$57.00Neutral$00.0000.00% ROIBIIBBiogen2/13/2025Lower Price Target$136.88$245.00Buy$000.0000.00% ROIGILDGilead Sciences2/12/2025Boost Price Target$103.52$96.00Neutral$000.0000.00% ROIMRNAModerna1/29/2025Downgrade$44.94$51.00Neutral$00.0000.00% ROIMRNAModerna1/28/2025Lower Price Target$43.47$99.00Buy$00.0000.00% ROIDNLIDenali Therapeutics1/28/2025Lower Price Target$22.99$40.00Buy$00.0000.00% ROIADPTAdaptive Biotechnologies1/28/2025Boost Price Target$7.76$7.50Neutral$00.0000.00% ROINTLAIntellia Therapeutics1/14/2025Lower Price Target$10.05$12.00Neutral$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenRoth CapitalWeiss RatingsCitigroupUBS GroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper Sandler Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
